Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sabin IPV 2-dose vs 3-dose schedule in Chinese infants
NCT03546634Phase 4Completed
- Sponsor
- Centers for Disease Control and Prevention
- Start
- May 2018
- Primary completion
- Jun 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Inactivated poliovirus vaccine (Sabin strain) in poliomyelitis (2 arms), sponsored by Centers for Disease Control and Prevention. Primary endpoint: Seroconversion rate at 10 months. Started May 2018; status: completed.
02
Drugs
Inactivated poliovirus vaccine (Sabin strain)
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT03546634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03546634.